- Home
- LNTH vs AVAL Comparison
LNTH vs AVAL Comparison
Compare LNTH & AVAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | AVAL |
|---|---|---|
| Founded | 1956 | 1994 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.0B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | AVAL |
|---|---|---|
| Price | $67.59 | $4.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $78.00 | N/A |
| AVG Volume (30 Days) | ★ 788.1K | 107.2K |
| Earning Date | 02-25-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 2.29% |
| EPS Growth | N/A | ★ 103.13 |
| EPS | ★ 2.39 | 0.02 |
| Revenue | $1,525,933,000.00 | ★ $3,419,775,032.00 |
| Revenue This Year | $0.01 | $46.54 |
| Revenue Next Year | $0.26 | $8.90 |
| P/E Ratio | $28.21 | ★ $12.89 |
| Revenue Growth | 1.95 | ★ 17.39 |
| 52 Week Low | $47.25 | $2.25 |
| 52 Week High | $111.29 | $4.75 |
Technical Indicators
Market Signals| Indicator | LNTH | AVAL |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 74.72 |
| Support Level | $63.37 | $4.11 |
| Resistance Level | $67.92 | $4.75 |
| Average True Range (ATR) | 2.06 | 0.13 |
| MACD | -0.37 | 0.06 |
| Stochastic Oscillator | 58.76 | 90.67 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About AVAL Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)
Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its segments include: Banking Services segment comprises Banking Services, fund management and trust businesses, storage companies and entities that manage low-value payment systems. Merchant Banking segment comprises Financial Sector (trust and brokerage), Gas and Energy Sector (includes natural gas and energy transportation and distribution businesses), Infrastructure Sector (includes road infrastructure projects, construction services, and operation and maintenance), Hotel Sector (includes hospitality services), Agribusiness Sector (includes palm oil, rubber and rice businesses). Pension and Severance Fund Management" segment comprise administrator of pension and severance funds; and Holding segment.